Figure 1.
The tumor microenvironment in FL. (A) Gene expression profiling in FL identified 2 immune response signatures (IR1 and IR2) that can be used to predict clinical outcome. IR1 is associated with genes expressed by non-neoplastic T cells, whereas IR2 is associated with genes expressed by macrophages. Subsequent studies have analyzed specific cell populations within the tumor microenvironment. (B) Increased frequency of Treg cells in the tumor microenvironment is generally associated with a favorable prognosis in FL, particularly when dispersed throughout the tumor. CCL22 secreted from lymphoma B cells induces the migration of CCR4+ Treg cells and may in part account for the increased number of Treg cells in FL. (C) TFH cells overexpress IL-4, which induces signal transducer and activator of transcription 6 (STAT6) activation in neighboring malignant B cells. In addition, TAMs overexpress IL-15, which triggers STAT5-dependent FL B-cell activation. TFH cooperate with this IL-15-mediated signal through CD40L-dependent transcriptional induction of STAT5. The transcriptional targets of STAT proteins play roles in cell cycle progression and cell survival. Therefore, TFH and TAMs in the tumor microenvironment are generally associated with poor prognosis in FL.